NUWELLIS INC (NUWE) Stock Price, Quote, News and Overview
NASDAQ:NUWE - Nasdaq - US67113Y6032 - Common Stock - Currency: USD
NUWE Quote, Performance and Key Statistics
0.871
-0.01 (-1.3%)
The current stock price of NUWE is 0.871 USD. In the past month the price decreased by -21.53%. In the past year, price decreased by -85.17%.
NUWE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.16 | 225.18B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.87 | 174.81B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.41 | 146.31B | ||
| SYK | STRYKER CORP | 29.3 | 136.31B | ||
| MDT | MEDTRONIC PLC | 15.68 | 107.41B | ||
| BDX | BECTON DICKINSON AND CO | 14.54 | 58.09B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.89 | 41.42B | ||
| IDXX | IDEXX LABORATORIES INC | 37.92 | 34.57B | ||
| RMD | RESMED INC | 24.26 | 31.49B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 29.71B | ||
| DXCM | DEXCOM INC | 40.52 | 26.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.38 | 22.99B |
Related stock screener links
About NUWE
Company Profile
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Info
NUWELLIS INC
12988 Valley View Rd
Eden Prairie MINNESOTA 55344 US
CEO: Nestor Jaramillo
Employees: 38
Company Website: https://www.nuwellis.com/
Investor Relations: http://ir.sunshineheart.com/
Phone: 19523454200
NUWELLIS INC / NUWE FAQ
What is the stock price of NUWELLIS INC today?
The current stock price of NUWE is 0.871 USD. The price decreased by -1.3% in the last trading session.
What is the ticker symbol for NUWELLIS INC stock?
The exchange symbol of NUWELLIS INC is NUWE and it is listed on the Nasdaq exchange.
On which exchange is NUWE stock listed?
NUWE stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NUWELLIS INC stock?
8 analysts have analysed NUWE and the average price target is 13.26 USD. This implies a price increase of 1422.39% is expected in the next year compared to the current price of 0.871. Check the NUWELLIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NUWELLIS INC worth?
NUWELLIS INC (NUWE) has a market capitalization of 3.81M USD. This makes NUWE a Nano Cap stock.
How many employees does NUWELLIS INC have?
NUWELLIS INC (NUWE) currently has 38 employees.
What are the support and resistance levels for NUWELLIS INC (NUWE) stock?
NUWELLIS INC (NUWE) has a resistance level at 0.94. Check the full technical report for a detailed analysis of NUWE support and resistance levels.
Is NUWELLIS INC (NUWE) expected to grow?
The Revenue of NUWELLIS INC (NUWE) is expected to grow by 18.66% in the next year. Check the estimates tab for more information on the NUWE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NUWELLIS INC (NUWE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NUWE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NUWE, evaluating the profitability, health, valuation and growth aspects
- NUWELLIS INC (NUWE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NUWELLIS INC (NUWE) Sales and EPS estimates to see what analysts future expectations are.
- NUWELLIS INC (NUWE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NUWELLIS INC (NUWE) Insider and Institutional Ownership to learn about the owners and their transactions.
- NUWELLIS INC (NUWE) Stock Chart to make your own analysis
- NUWELLIS INC (NUWE) Latest news and press-releases to stay up to date.
Does NUWELLIS INC (NUWE) stock pay dividends?
NUWE does not pay a dividend.
When does NUWELLIS INC (NUWE) report earnings?
NUWELLIS INC (NUWE) will report earnings on 2025-05-05, before the market open.
What is the Price/Earnings (PE) ratio of NUWELLIS INC (NUWE)?
NUWELLIS INC (NUWE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-38.81).
What is the Short Interest ratio of NUWELLIS INC (NUWE) stock?
The outstanding short interest for NUWELLIS INC (NUWE) is 4.79% of its float. Check the ownership tab for more information on the NUWE short interest.
NUWE Technical Analysis
NUWE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NUWE. The financial health of NUWE is average, but there are quite some concerns on its profitability.
NUWE Financial Highlights
Over the last trailing twelve months NUWE reported a non-GAAP Earnings per Share(EPS) of -38.81. The EPS increased by 91.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -107.7% | ||
| ROE | -162.7% | ||
| Debt/Equity | 0 |
NUWE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to NUWE. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 94.59% and a revenue growth 18.66% for NUWE